About WebBasedCME.com

Applying the latest technological advances in education and message broadcasting, WebBasedCME.com will distribute ease-of-access pertinent information directly to the professionals that desire to keep up-to-date with medical breakthroughs.

more...


More Online CME Resources

The Caring For Diabetes Educational Forum

Case Based CME - The Amazing Race to Tight Glycemic Control

American Academy of Family Physicians

Medscape - CME Center






















Activities

  • New Developments in Insulin Therapy: Expert  Answers to Your Clinical Questions
  • Gastric Cancer
  • Slide 2
  • Slide 3
  • Slide 4



Current CME Activities



DIABETES :: Applied Practical Learning

The Insulin Challenge: A Multimedia Guide to Mastering Modern Insulin Therapy
Do you consider yourself to be an expert in insulin therapy? Challenge yourself by completing 3 different levels of difficulty in this fun and interactive game! Upon entering the activity, you will start at the novice level and can advance to the next level after answering 3 of the 6 questions on that level correctly. You will face the same challenge at the intermediate level. Once you access the third and final level of difficulty, you can confirm your expertise by answering all 6 questions at the level and view feedback concerning your answers.

DIABETES :: Monograph

Diabetes Fact Finder: Helping Your Patients Get the Most Out of GLP-1 Receptor Agonists
This educational activity is designed to offer practical, evidence-based considerations for appropriately applying the use of GLP-1 receptor agonists for the management of T2DM. Additionally, this online publication features expert discussions designed to provide information that can be immediately applied to clinical practice.

TUBERCULOSIS :: Webcast Series

Tuberculosis Testing: An Online Tutorial Using IGRA
This online tutorial will provide practical information that will help nurses, technicians and laboratory staff, obtain and process IGRA specimens consistent with the approved labeling of the tests to assure high quality control and avoid unnecessary treatment referrals.


Past CME Activities



DIABETES :: Applied Practical Learning

New Developments in Insulin Therapy: Expert Answers to Your Clinical Questions
This highly interactive educational activity will familiarize diabetes specialists with clinical trial data focused on insulin therapy, including highlights recently reported at the American Diabetes Association 75th Scientific Sessions. Expert discussions will focus on individualizing insulin therapy according to patient comorbidities and complications, using insulin in combination with other antihyperglycemic agents to reduce hypoglycemia and weight gain, treating patients with severe insulin resistance, reviewing advances in insulin delivery technology, improving adherence to insulin therapy, and providing a scientific and clinical overview of recently approved and emerging insulins. Participants will obtain practical information to assist with translating research findings into clinical practice.

ONCOLOGY :: Monograph

Expert Insights on Expanding Treatment Options for Patients with Advanced Gastric Cancer
This educational activity will increase learners’ knowledge of the current understanding of tumor biology, risk factors, and management of gastric cancer as well as the rationale for and mechanisms of action of molecularly targeted agents currently approved or under investigation for the treatment of advanced gastric cancer. Additionally, this online publication features expert discussion of a realistic, clinical case designed to provide information immediately applicable to clinical practice. Corresponding faculty discussion has been captured to provide expert perspective regarding current clinical evidence and treatment options.

DIABETES :: Online Case Study

Diabetes Stumpers: Challenging Cases in T2DM and the Role of GLP-1 RAs for Glycemic Control
In this activity, participants will be given the opportunity to analyze up to 3 case studies, focusing on the role of GLP-1 RAs in T2DM. Each case study exercise will contain clinical information about GLP-1 RA therapy that can be accessed by the user at their discretion. Throughout the activity, participants will collect key information consistent with each patient’s preferences and goals, assess their current treatment T2DM regimen, and evaluate the clinical evidence for GLP-1 RA therapy in the context of the patient case.

DIABETES :: Online Case Study

Clues to Patient-Centered Hyperglycemia Management in Patients With T2DM

This program is designed to facilitate competent patient-centered diabetes care by:
  • Reviewing current patient-centered guidelines, focusing on the management of hyperglycemia in T2DM
  • Considering the applicability of therapies in the context of specific clinical circumstances
  • Introducing information on new and emerging therapies for T2DM
  • Providing an opportunity for HCPs to apply their newly acquired knowledge

DIABETES :: Applied Practical Learning

GLP-1 Receptor Agonists: What’s Known? What’s New?
Content for this activity is based on the live symposium “GLP-1 Receptor Agonists: What’s Known? What’s New?” that was presented as a satellite symposium at ENDO 2013 on Saturday, June 15, 2013, in San Francisco, California.

SBS :: Webcast Series

GI Journal Club
Short bowel syndrome (SBS) is caused by functional or anatomical loss of extensive segments of the small intestine, resulting in severely compromised absorptive capacity. Varying degrees of intestinal adaptation to SBS can be attained through multidisciplinary interventions, including surgical, medical, and nutritional management. Clinical trials demonstrate that both recombinant human growth hormone and teduglutide, an analogue of the intestinal peptide GLP-2, have the potential to promote intestinal adaptation in patients with SBS. Physicians, pharmacists, nurses, and dietitians can receive continuing education credit for participating in this webcast, based on the CME/CE symposium "GI Journal Club: Current and Emerging Approaches to Promoting Intestinal Adaptation in Adults With Short Bowel Syndrome," presented Monday, February 11, 2013 at Clinical Nutrition Week 2013. This activity is supported by an educational grant from NPS Pharmaceuticals, Inc.

DIABETES :: Applied Practical Learning

New Developments in Insulin Therapy: Expert Insights in Individualizing Treatment in Type 2 Diabetes
This educational activity will familiarize diabetes specialists with clinical trial data pertaining to current and future insulin therapy as reported at the American Diabetes Association 72nd Scientific Sessions. By reviewing recent findings, participants will obtain practical, personalized clinical guidance to help them customize insulin regimens that are consistent with the anticipated benefits and risks for individual patients. This activity will also highlight emerging advances in insulin therapy that have the potential to impact future treatment decisions.

DIABETES :: Applied Practical Learning

Diabetes Mythbusters: An Investigation Into Common Misperceptions Regarding the Use of GLP-1 Receptor Agonists for Type 2 Diabetes
This activity is designed to help participants recognize that GLP-1RAs can provide effective glycemic control with several nonglycemic effects that frequently align with individual patient characteristics and goals. Additionally, tools to better manage provider-patient discussions and aid patients in identifying reputable education sources will be provided.

DIABETES :: Applied Practical Learning

Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice
This activity and the live CME symposium on which it is based are supported by an educational grant from Novo Nordisk, Inc. The live symposium, “Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice,”—presented Thursday, October 18, 2012, at the American Academy of Family Physicians (AAFP) Scientific Assembly—was sponsored by the Institute for Medical and Nursing Education, Inc (IMNE). This event was not part of the official AAFP Scientific Assembly.

DIABETES :: Applied Practical Learning

Insulin Therapy is Still Hot and Getting Hotter
The evidence base surrounding insulin therapy in diabetes is changing rapidly. Expert discussion of current studies of investigational insulins, treatment regimens, and delivery technologies will help participants gain perspective on how potential new options might be used to individualize therapy.

DIABETES :: Webcast Series

AADE Recorded Webinars
Available whenever you are, AADE Recorded Webinars are the flexible resource that will keep your expertise up-to-the-minute and your busy schedule on track. Sign up now, then participate at your convenience from the comfort of your office or home.

DIABETES :: Applied Practical Learning

Hot Topics - New Developments in Insulin Therapy
Insulin therapy is the most vital and efficacious treatment for diabetes, yet it remains the most complex. Current issues in insulin therapy include setting appropriate individual glycemic targets, using currently available insulins more effectively and safely, and using insulin in combination with incretin therapies. Recent research has paradoxically clarified some of these issues, but further complicated others. The future of insulin therapy will offer additional opportunities to individualize therapy, as investigations are designed to explore various strategies to deliver insulin in a more perfectly physiologic manner, including new types of insulin analogues, new routes of administration, and new delivery technologies. This activity will discuss recent findings pertaining to both the present and future of insulin therapy.

DIABETES :: Applied Practical Learning

Build A Case in Type 2 Diabetes: Your Patients and GLP-1 Receptor Agonist Therapy
This CME activity is intended to increase understanding of the characteristics of GLP-1 RAs, including efficacy, nonglycemic effects, and safety profiles, relative to other antidiabetic agents, and to provide information to facilitate their appropriate and successful use in individualized treatment regimens for patients with T2D. The activity is based on a live satellite symposium conducted during the 2011 American Academy of Family Physicians (AAFP) Scientific Assembly. Case scenarios, developed according to input from participants in the live symposium, provide the framework for discussing GLP-1 RAs in the context of caring for patients with T2D.

DIABETES :: Applied Practical Learning

Building A Solid Foundation in Diabetes: The Nuts and Bolts of Insulin Therapy
In this activity, you will be asked to consider a patient likely to be encountered in family practice. The case will begin at a basic level and become more complex throughout the activity, as new factors are added requiring additional consideration and treatment adjustments. This approach will permit piecewise acquisition of knowledge within the framework of a complete case using a jigsaw-puzzle format, engaging you in real-time learning with immediate clinical applicability. You will be able to submit and compare your responses to other participants.

DIABETES :: Applied Practical Learning

No Sugar Coating Required: Real-Life Application of Incretin-Based Therapies in Type 2 Diabetes
Incretin-based therapies, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors, provide effective glycemic control in type 2 diabetes (T2D), paired with beneficial nonglycemic effects on weight, lipids, and blood pressure.

This unique program will highlight the comparative effectiveness and safety of these agents, appropriate patient selection, timely treatment initiation, and common barriers to glycemic control through the use of a simulated patient.

This activity is intended for osteopathic physicians who treat patients with T2D.

DIABETES :: Online Activity

Hot Seat Discussion on GLP-1 Receptor Agonists ...Your Questions Answered
Recent clinical trials have demonstrated the therapeutic efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) at different stages of diabetes progression, and exploratory studies suggest the potential for therapeutic uses other than glycemic control in patients with type 2 diabetes mellitus (T2DM). This continuing medical education (CME/CE) symposium will focus on hot topics arising from the most current information relevant to GLP-1 RAs.

This activity includes an introductory segment followed by 8 "hot topic" discussions, each consisting of comparative answer polling questions; a short written excerpt of relevant, corresponding clinical data; and audio clips of the faculty roundtable discussion derived from questions received during the live activity.

DIABETES :: Applied Practical Learning

Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy
This activity, and the live symposium on which it is based, were supported by an education grant from Novo Nordisk, Inc. The live symposium, “Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy,” presented Thursday, March 17, 2011, at the American College of Osteopathic Family Physicians’ (ACOFP) 48th Annual Convention & Exhibition in San Antonio, Texas, was sponsored by the ACOFP and developed by the Institute for Medical and Nursing Education.

DIABETES :: Online Case Study

Identifying the Pathway to Successful Patient Care: Practical Implementation of Incretin-Based Therapies in Type 2 Diabetes
This activity is intended for family physicians and other HCPs who treat patients with T2D.

DIABETES :: Webcast Series

Prospects for GLP-1 Receptor Agonists: When, Who, and How to Treat
This activity is intended for physicians, nurses, nurse practitioners, physician assistants, certified diabetes educators, and other HCPs who care for patients with T2DM and manage the complications related to this disease.

DIABETES :: Online Case Study

Optimizing Insulin Therapy: A Case-based Activity
This activity is intended for physicians, diabetes educators, nurses and other healthcare professionals who treat patients with diabetes.

DIABETES :: Monograph

Peak Issues 4: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with 2 diabetes.

DIABETES :: Monograph

Peak Issues 3: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.

ONCOLOGY :: Applied Practical Learning

Women's Oncology Masters Series: The Evolving Role of Targeted Therapy in Breast and Ovarian Cancers
This activity is intended for gynecologic oncologists, medical oncologists, surgical oncologists and other oncology HCPs who want to further the care of their patients with advanced breast cancer and ovarian cancer.

DIABETES :: Webcast Series

Evolving Landscape of Incretin-Based Therapies Webcast
Type 2 diabetes is a progressive disease that often requires treatment intensification using several therapeutic agents. Incretin-based therapies address numerous pathophysiologic defects in type 2 diabetes with limited side effects.This content will discuss incretin-based therapies in depth, from pathophysiologic effects to clinical use, and will incorporate interactive questions whereby you can evaluate your answers against those of your colleagues, along with a concluding faculty panel discussion.

DIABETES :: Online Case Study

Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
This activity is composed of 3 interactive case studies which explore options for the clinical use of incretin-based therapies in diverse clinical scenarios. Because each case study examines different aspects of diabetes care, completion of all 3 is expected to provide a broader perspective regarding the use of the 2 available classes of incretin-based therapies.

DIABETES :: Monograph

Peak Issues 2: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.

DIABETES :: Monograph

Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes
Incretin-based therapies, with their unique pathophysiology, have rapidly evolved into a therapeutic option that can fill this role. The symposium content, enhanced with an audience response system (ARS) and a case-based panel discussion, will concentrate on various critical aspects of successful type 2 diabetes disease management. Patient selection and strategies for advancement to incretin-based therapies are among the topics that will be discussed.

DIABETES :: Monograph

Peak Issues: Clinical Use Of Incretin-Based Therapies To Promote PPG Control In Type 2 Diabetes
This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.

DIABETES :: Monograph

Incretin Insider: incretin Mimetics 2008 in Review
A wealth of new data on incretin mimetics were released and published in 2008. This publication will summarize these key findings and offer insight into the clinical utility of incretin mimetics. This activity is intended for endocrinologists as well as other physicians and healthcare professionals treating patients with type 2 diabetes.

INFLUENZA :: Teaching Kit

Antiviral Therapy for Influenza
Infectious disease specialists frequently act as consultants to primary care physicians and are therefore ideally qualified, by virtue of their training and function within the healthcare system, to educate their colleagues on this topic. This Teaching Kit provides several tools you can use to help other physicians address the multifaceted challenges of influenza management in view of recent guideline updates.

DIABETES :: Webcast Series

Managing FPG and PPG With Incretin-Based Therapies: A Therapeutic Double Play
In the area of clinical management of diabetes, an urgent and ongoing need for appropriate treatment remains. In order to effectively manage this widespread disease, clinical professionals need to fully understand diabetes and its treatment options.

DIABETES :: Online Case Study

The Amazing Race to Tight Glycemic Control
Interactive Online CME Cases from IMP's ADA 2008 Symposium entitled 'THE AMAZING RACE to Tight Glycemic Control: Managing Complex Patients With Insulin Analogs'

DIABETES :: Webcast Series

ADA Summary Conference Report 2008
In Conjunction with the 2008 American Diabetes Association's 68th Annual Scientific Sessions this educational activity is designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with type 2 diabetes.

SEPSIS :: Applied Practical Learning

Early Identification and Treatment Protocols in Managing Severe Sepsis CD-ROM
This program will feature discussions by leading experts regarding severe sepsis recognition and management in adult patients. Participants will learn about current and emerging methods for early identification of severe sepsis, benefits of protocols for managing the condition, and resources for protocol development and implementation.

INSOMNIA :: Webcast Series

Redefining Insomnia: State-of-the-Science in Insomnia Management
Incretin-based therapies not only offer the potential to address many of the pathophysiologic challenges of type 2 diabetes but also show great promise in addressing clinical challenges. This educational program will provide current information on pathophysiologic challenges in type 2 diabetes and potential solutions offered by incretin-based therapies.

INSOMNIA :: Podcast Series

Redefining Insomnia: State-of-the-Science in Insomnia Management
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.

INSOMNIA :: Applied Practical Learning

Redefining Insomnia: State-of-the-Science in Insomnia Management
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.

INSOMNIA :: Monograph

Redefining Insomnia: State-of-the-Science in Insomnia Management
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.

OBESITY :: Applied Practical Learning

Cardiometabolic Risk Reduction in the Metabolic Syndrome and Type 2 Diabetes
This activity was developed for physicians, nurses, and pharmacists involved in the management of patients with obesity and cardiometabolic risk factors.